South Wales, Oct. 6 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "ION Therapeutics" on Sept. 15. The details about the trademark application no. UK00004445417 published in the journal no. 2026/040 (Oct. 2).
With D Young & Co LLP as representative, ION Therapeutics Limited filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceutical products for the treatment of ocular diseases; pharmaceutical products for the treatment of ocular disorders; injectable pharmaceuticals for the treatment of ocular diseases; injectable pharmaceuticals for the treatment of ocular disorders; gene therapy medicinal products; gene therapy medicinal products for the treatment of ocular diseases and disorders.
Class 10 : Medical apparatus and devices; medical apparatus and devices for the treatment of ocular diseases and disorders; medical apparatus and devices for the administration of a therapy.
Class 42 : Medical and scientific research in the field of ocular diseases and disorders; medical and scientific research in the field of gene therapy and genetic testing; medical and scientific research in the field of genetic treatment of ocular diseases and disorders; medical and scientific research in the field of ocular drug delivery; medical and scientific research information in the field of gene therapy and genetic testing; medical and scientific research information in the field of ocular diseases and disorders; pharmaceutical research and development services in the field of ocular diseases and disorders; clinical trials in the field of ocular diseases and disorder; conducting clinical trials in the field of ocular diseases and disorders; genetic testing for medical and scientific research purposes in the field of ocular diseases and disorders; information, advice and consultancy in relation to the foregoing.
Class 44 : Medical surgical services relating to gene therapy, genetic testing, ocular diseases and ocular disorders; medical and surgical diagnosis relating to gene therapy, genetic testing, ocular diseases and ocular disorders; medical testing relating to relating to gene therapy, genetic testing, ocular diseases and ocular disorders; medical consultations, medical services and healthcare services relating to gene therapy, genetic testing, ocular diseases and ocular disorders; medical and health services relating to DNA, genetics and genetic testing; information, advice and consultancy in relation to the foregoing.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004445417
Disclaimer: Curated by HT Syndication.
